Emi A. Lutz - Concepedia

Author

Emi A. Lutz

Massachusetts Institute of Technology ORCID

Also Known As

Emi A Lutz, Emi A. Lutz, Emi Lutz

Publications

916

Citations

H-Index

Concepts

All Affiliations

Massachusetts Institute of Technology Ragon Institute of MGH, MIT and Harvard Scripps Research Institute

About

Emi A. Lutz is an author at Massachusetts Institute of Technology specializing in medicine, immunology, and tumor immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	571
2	Immunology	5	5	571
3	Cell Biology	3	3	398
4	Natural Sciences	1	1	46
5	Allergy	1	1	46

Emi A. Lutz

Publications

904

Citations

H-Index

Page 1

	Year	Citations
Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity Ellen Duong, Tim Fessenden, Emi A. Lutz, Immunity Tumor ImmunologyCancer ImmunosurveillanceAutoimmune DiseaseImmunologyTumor Immunity	2021	322
Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy Noor Momin, Naveen K. Mehta, Nitasha R. Bennett, Science Translational Medicine	2019	199
Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity Yash Agarwal, Lauren E. Milling, Jason Y.H. Chang, Nature Biomedical Engineering InflammationCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2022	127
Maximizing response to intratumoral immunotherapy in mice by tuning local retention Noor Momin, Joseph R. Palmeri, Emi A. Lutz, Nature Communications	2022	75
Efficient Identification of Murine M2 Macrophage Peptide Targeting Ligands by Phage Display and Next-Generation Sequencing Gary W. Liu, Brynn R. Livesay, Nataly Kacherovsky, Bioconjugate Chemistry Drug TargetBiomolecular ToolImmunologyMolecular BiologyPhage Display	2015	46
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies Brianna M. Lax, Joseph R. Palmeri, Emi A. Lutz, Proceedings of the National Academy of Sciences T-regulatory CellImmunologyTreg DepletionRegulatory T CellsAntigen Processing	2023	46
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies Emi A. Lutz, Yash Agarwal, Noor Momin, Proceedings of the National Academy of Sciences ImmunoeditingImmunologyImmune RegulationAntitumor EfficacyIfnβ Therapies	2022	30
Intratumoral nanobody–IL-2 fusions that bind the tumor extracellular matrix suppress solid tumor growth in mice Emi A. Lutz, Noor Jailkhani, Noor Momin, PNAS Nexus	2022	25
CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs Joseph R. Palmeri, Brianna M. Lax, Joshua M. Peters, Nature Communications	2024	18
An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy Sarah C. Cowles, Allison Sheen, Luciano Santollani, mAbs	2022	16

Page 1